First Fibroblast Injection in Trial for Spinal Disc Regeneration

By Julie A. Vetalice

SpinalCyte announced the first injection in a clinical trial of CybroCell fibroblasts for spinal disc regeneration. The procedure was completed in under 15 minutes using a local anesthetic, and the patient was discharged within an hour.

SpinalCyte received Institutional Review Board approval to commence the randomized, placebo-controlled, double-blind Phase I clinical trial with CybroCell dermal fibroblast cell product in late 4Q16.

Sources: SpinalCyte, LLC; ORTHOWORLD Inc.

Product Labels: PRP/Cell-Based/Osteoinductive Materials

Tags: Product Launch